Li et al., 2015 - Google Patents

Total chemical synthesis of human interferon alpha‐2b via native chemical ligation

Li et al., 2015

View HTML
Document ID
10079835094192257343
Author
Li J
Lehmann C
Chen X
Romerio F
Lu W
Publication year
Publication venue
Journal of peptide science

External Links

Snippet

Interferon‐alpha (IFNα) is a cytokine that orchestrates innate and adaptive immune responses and potently inhibits proliferation of normal and tumor cells. These properties have warranted the use of IFNα in clinical practice for the treatment of several viral infections …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links

Similar Documents

Publication Publication Date Title
Walensky et al. Hydrocarbon-stapled peptides: principles, practice, and progress: miniperspective
US20230106577A1 (en) Peptidomimetic macrocycles and uses thereof
Dwyer et al. Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus
Ueda et al. Structure− activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities
Bluntzer et al. Designing stapled peptides to inhibit protein‐protein interactions: an analysis of successes in a rapidly changing field
Neumann‐Haefelin et al. Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations
March et al. Substrate-based cyclic peptidomimetics of Phe-Ile-Val that inhibit HIV-1 protease using a novel enzyme-binding mode
McFarlane et al. Molecular and cellular factors determining the functional pleiotropy of cytokines
Li et al. Total chemical synthesis of human interferon alpha‐2b via native chemical ligation
US20100278853A1 (en) Constrained hiv v3 loop peptides as novel immunogens and receptor antagonists
Skelton et al. Structure− Function Analysis of a Phage Display-Derived Peptide That Binds to Insulin-like Growth Factor Binding Protein 1
Secchi et al. Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides
Gozdek et al. NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: its mechanism of action and antiviral activity in the replicon system
Zhang et al. Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors
Stangler et al. Competitive displacement of full-length HIV-1 Nef from the Hck SH3 domain by a high-affinity artificial peptide
Gomara et al. Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide
KR20190062490A (en) Type III mutant interferon and < RTI ID = 0.0 >
Outlaw et al. Effects of single α-to-β residue replacements on recognition of an extended segment in a viral fusion protein
Halpin et al. Molecular determinants of TRAF6 binding specificity suggest that native interaction partners are not optimized for affinity
Szewczuk et al. Immunosuppressory activity of ubiquitin fragments containing retro‐RGD sequence
Guan et al. Structural and Functional Characterization of a Fish Type I Subgroup d IFN Reveals Its Binding to Receptors
WO2014159947A1 (en) High affinity digoxigenin binding proteins
Nudelman et al. Intermolecular Interactions in a 44 kDa Interferon− Receptor Complex Detected by Asymmetric Reverse-Protonation and Two-Dimensional NOESY
Akaberi et al. Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Chandramohan et al. Design-Rules for Stapled Alpha-Helical Peptides with On-Target In Vivo Activity: Application to Mdm2/X dual antagonists